E, P., F, C., A, C., L, P., P, R., S, S., . . . G, S. (2020). Everolimus in kidney transplant recipients at high cardiovascular risk: A narrative review. Journal of nephrology, 33(1), 69. https://doi.org/10.1007/s40620-019-00609-y
Chicago Style (17th ed.) CitationE, Paoletti, Citterio F, Corsini A, Potena L, Rigotti P, Sandrini S, Bussalino E, and Stallone G. "Everolimus in Kidney Transplant Recipients at High Cardiovascular Risk: A Narrative Review." Journal of Nephrology 33, no. 1 (2020): 69. https://doi.org/10.1007/s40620-019-00609-y.
MLA (9th ed.) CitationE, Paoletti, et al. "Everolimus in Kidney Transplant Recipients at High Cardiovascular Risk: A Narrative Review." Journal of Nephrology, vol. 33, no. 1, 2020, p. 69, https://doi.org/10.1007/s40620-019-00609-y.